Merck and Mayo Clinic Partner to Accelerate AI-Driven Drug Discovery and Development
Merck, known as MSD outside the United States and Canada, has entered into a strategic research and development agreement with Mayo Clinic, one of the world’s leading hospital systems, to advance the use of artificial intelligence (AI), advanced analytics and multimodal clinical data in drug discovery and development.
AI-Driven Drug Discovery And Development | 20/02/2026 | By Darshana | 110
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy